dracorhodin has been researched along with Cystic Angiomatosis Of Bone, Diffuse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Chen, L; Chen, Z; He, W; Liu, Y; Ma, C; Wang, C; Wang, Z; Wei, Z; Xu, J; Zhang, Q; Zhou, C | 1 |
1 other study(ies) available for dracorhodin and Cystic Angiomatosis Of Bone, Diffuse
Article | Year |
---|---|
Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL-stimulated NFATc1 activity.
Topics: Animals; Antineoplastic Agents; Benzopyrans; Calcium Signaling; Cells, Cultured; Drugs, Chinese Herbal; Female; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteolysis, Essential; Podosomes; RANK Ligand; Transcription Factor RelA | 2020 |